ArchiMed

ArchiMed is an independent private equity firm founded in 2014 and based in Lyon, France, with an office in New York. It focuses on buyouts and growth capital in the healthcare sector, including care and wellness, homecare and wellness centers, telemedicine, medtech, medical devices, diagnostics, healthcare information technology, life science tools, hygiene products, biopharma, animal health, contract research, and public health initiatives. The firm predominantly targets Europe, especially Western Europe, and may consider opportunities in the United States. It typically invests between €2 million and €50 million per transaction, with portfolio company revenues ranging from €5 million to €100 million, and sometimes higher with co-investors. It takes both minority and majority stakes, mostly in unlisted companies. ArchiMed is funded by the founding team and external investors, operating independently from large financial sponsors.